Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Intrinsic Value
The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 13.28 HKD. Compared to the current market price of 13.9 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Biocytogen Pharmaceuticals Beijing Co Ltd
Fundamental Analysis
Want a deep‑dive on Biocytogen Pharmaceuticals Beijing Co Ltd?
Request it below and we’ll move it up the queue.


Revenue & Expenses Breakdown
Biocytogen Pharmaceuticals Beijing Co Ltd
Balance Sheet Decomposition
Biocytogen Pharmaceuticals Beijing Co Ltd
Current Assets | 816.5m |
Cash & Short-Term Investments | 403.9m |
Receivables | 229.6m |
Other Current Assets | 183.1m |
Non-Current Assets | 1.6B |
Long-Term Investments | 159m |
PP&E | 1.3B |
Intangibles | 20.7m |
Other Non-Current Assets | 69.6m |
Free Cash Flow Analysis
Biocytogen Pharmaceuticals Beijing Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Biocytogen Pharmaceuticals Beijing Co Ltd
Revenue
|
980.5m
CNY
|
Cost of Revenue
|
-218.9m
CNY
|
Gross Profit
|
761.5m
CNY
|
Operating Expenses
|
-611m
CNY
|
Operating Income
|
150.5m
CNY
|
Other Expenses
|
-117m
CNY
|
Net Income
|
33.5m
CNY
|
Profitability Score
Profitability Due Diligence
Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Biocytogen Pharmaceuticals Beijing Co Ltd
According to Wall Street analysts, the average 1-year price target for Biocytogen Pharmaceuticals Beijing Co Ltd is 15.17 HKD with a low forecast of 13.62 HKD and a high forecast of 17.06 HKD.
Dividends
Current shareholder yield for Biocytogen Pharmaceuticals Beijing Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 13.28 HKD.
Compared to the current market price of 13.9 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Overvalued by 4%.